Offer - Urjas Oil for just ₹ 1
Calinta, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Calcium Deficiency, Calcium Deficiency, Post Menopausal Osteoporosis. Secondary and off-label uses of Calinta have also been mentioned below.
The right dosage of Calinta depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Calinta also has some side effects, the most common being Musculoskeletal Pain (Bone, Muscle or Joint), Diarrhoea, Heartburn. Besides the aforementioned side effects, there are other adverse effects of Calinta as well, which are listed below. These side effects of Calinta are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Calinta is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Calinta's effects on the liver, heart and kidney are discussed below in the Calinta related warnings section.
Calinta can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Calinta in conditions like Kidney Disease, Heart Disease, Kidney Disease. The section on Calinta contraindications lists all such conditions.
Drug interactions for Calinta have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Calinta, it is important to know that it is not safe while driving, and is not habit-forming.
Calinta is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Calinta safe for pregnant women?
Calinta may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Calinta again without your doctor's advice.
Is the use of Calinta safe during breastfeeding?
Breastfeeding women may feel side effects of Calinta. If you see any side effects, stop taking Calinta immediately and talk to your doctor. Take Calinta again, only after your doctor's advice.
What is the effect of Calinta on the Kidneys?
Very few cases of side effects of Calinta on kidney have been reported.
What is the effect of Calinta on the Liver?
Very few cases of side effects of Calinta on the liver have been reported.
What is the effect of Calinta on the Heart?
Calinta has very mild side effects on the heart.
Calinta should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Calinta unless your doctor advises you to do so -
Is this Calinta habit forming or addictive?
Yes, Calinta can get addictive. Consume it only after doctor's advise.
Is it safe to drive or operate heavy machinery when consuming?
After taking Calinta you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Calinta is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Calinta has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Calinta
Due to the absence of research, it is difficult to say how Calinta and food will interact.
Interaction between Alcohol and Calinta
Drinking alcohol while taking Calinta may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1276-1278
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 340-342
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rocaltrol® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Calcijex® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Boniva® (ibandronate sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Boniva® (ibandronate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pentetate zinc trisodium injection (Zn-DTPA)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 680
